JPWO2020227016A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020227016A5 JPWO2020227016A5 JP2021565115A JP2021565115A JPWO2020227016A5 JP WO2020227016 A5 JPWO2020227016 A5 JP WO2020227016A5 JP 2021565115 A JP2021565115 A JP 2021565115A JP 2021565115 A JP2021565115 A JP 2021565115A JP WO2020227016 A5 JPWO2020227016 A5 JP WO2020227016A5
- Authority
- JP
- Japan
- Prior art keywords
- capture
- seq
- nos
- oligonucleotide
- oligonucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (22)
(a)配列番号1~64から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット1と、
(b)配列番号65~122から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット2と、
(c)配列番号123~186から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット3と、
(d)配列番号187~250から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット4と、
(e)配列番号251~308から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット5と、
(f)配列番号309~372から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット6と、
(g)配列番号373~436から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット7と、
(h)配列番号437~494から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット8と、
(i)配列番号495~558から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット9と、
(j)配列番号559~662から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット10と、
(k)配列番号623~680から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット11と、
(l)配列番号681~744から選択されるヌクレオチド配列を有する捕捉オリゴヌクレオチドを含む、親捕捉セット12と、から選択される、2つ以上の非交差反応性捕捉オリゴヌクレオチドのセット。 A set of two or more non-cross-reactive capture oligonucleotides (“capture set”) , said capture set being a subset of the set of parent capture oligonucleotides (“parent capture set”) , said Each capture oligonucleotide in a capture set has: a) a nucleotide sequence comprising at least 20 contiguous nucleotides of a nucleotide sequence from said parental capture set , or b) at least 95% of a nucleotide sequence from said parental capture set. wherein said parental capture set comprises a nucleotide sequence having the identity of
(a) a parent capture set 1 comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOs: 1-64;
(b) parental capture set 2, comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 65-122;
(c) parental capture set 3, comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOs: 123-186;
(d) parental capture set 4, comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 187-250;
(e) parental capture set 5, comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 251-308;
(f) parental capture set 6, comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 309-372;
(g) parental capture set 7, comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 373-436;
(h) a parent capture set 8 comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 437-494;
(i) a parent capture set 9 comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 495-558;
(j) a parent capture set 10 comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOs:559-662;
(k) a parent capture set 11 comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOS: 623-680;
(l) a set of two or more non-cross-reactive capture oligonucleotides selected from a parent capture set 12 comprising capture oligonucleotides having nucleotide sequences selected from SEQ ID NOs:681-744;
(a)配列番号1~64から選択される配列の少なくとも20個の連続したヌクレオチドを有する捕捉オリゴヌクレオチドと、
(b)配列番号1~64から選択される配列に対する少なくとも95%の同一性を有する配列を含む捕捉オリゴヌクレオチドと、
(c)配列番号1~64から選択される配列に対する少なくとも95%の同一性を有する配列の少なくとも20個の連続したヌクレオチドを有する捕捉オリゴヌクレオチドと、
(d)配列番号1~64から選択される配列を含む捕捉オリゴヌクレオチドと、
(e)(a)~(d)のうちのいずれかから選択される捕捉オリゴヌクレオチドと、から選択される、請求項1に記載の捕捉セット。 each capture oligonucleotide in the capture set comprising:
(a) a capture oligonucleotide having at least 20 contiguous nucleotides of a sequence selected from SEQ ID NOs: 1-64;
(b) a capture oligonucleotide comprising a sequence having at least 95 % identity to a sequence selected from SEQ ID NOs: 1-64;
(c) a capture oligonucleotide having at least 20 contiguous nucleotides of a sequence having at least 95 % identity to a sequence selected from SEQ ID NOs: 1-64;
(d) a capture oligonucleotide comprising a sequence selected from SEQ ID NOs: 1-64;
(e) a capture oligonucleotide selected from any of (a ) -(d).
(a)配列番号1~10から選択される配列の少なくとも20個の連続したヌクレオチドを有する配列を含む捕捉オリゴヌクレオチドと、
(b)配列番号1~10から選択される配列に対する少なくとも95%の同一性を有する配列を含む捕捉オリゴヌクレオチドと、
(c)配列番号1~10から選択される配列に対する少なくとも95%の同一性を有する配列の少なくとも20個の連続したヌクレオチドを有する捕捉オリゴヌクレオチドと、
(d)配列番号1~10から選択される配列を含む捕捉オリゴヌクレオチドと、
(e)(a)~(d)のうちのいずれかから選択される捕捉オリゴヌクレオチドと、から選択される、請求項1又は2に記載の捕捉セット。 each capture oligonucleotide in the set comprising:
(a) a capture oligonucleotide comprising a sequence having at least 20 contiguous nucleotides of a sequence selected from SEQ ID NOs: 1-10;
(b) a capture oligonucleotide comprising a sequence having at least 95 % identity to a sequence selected from SEQ ID NOs: 1-10;
(c) a capture oligonucleotide having at least 20 contiguous nucleotides of a sequence having at least 95 % identity to a sequence selected from SEQ ID NOS: 1-10;
(d) a capture oligonucleotide comprising a sequence selected from SEQ ID NOs: 1-10;
(e) a capture oligonucleotide selected from any of (a)-( d ).
請求項4に記載の捕捉セット。 said reactive functional group is attached to said capture oligonucleotide via a linker;
5. The capture set of claim 4 .
(a)配列番号745~808から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット1と、
(b)配列番号809~866から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット2と、
(c)配列番号867~930から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット3と、
(d)配列番号931~994から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット4と、
(e)配列番号995~1052から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット5と、
(f)配列番号1053~1116から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット6と、
(g)配列番号1117~1180から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット7と、
(h)配列番号1181~1238から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット8と、
(i)配列番号1239~1302から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット9と、
(j)配列番号1303~1366から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット10と、
(k)配列番号1367~1424から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット11と、
(l)配列番号1425~1488から選択されるヌクレオチド配列を有するオリゴヌクレオチドタグを含む、親タグセット12と、から選択される、2つ以上の非交差反応性オリゴヌクレオチドタグのセット。 A set of two or more non-cross-reactive oligonucleotide tags ("tag set") , said set of oligonucleotide tags being a subset of the set of parent oligonucleotide tags ("parent tag set") , said each oligonucleotide in the tag set has: a) a nucleotide sequence comprising at least 20 contiguous nucleotides of a nucleotide sequence from said parent tag set ; or b) at least 95 nucleotide sequences from said parent tag set. % identity , the parent tag set comprising:
(a) parent tag set 1, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOS: 745-808;
(b) parent tag set 2, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOs:809-866;
(c) parent tag set 3, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOS:867-930;
(d) parent tag set 4, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOS: 931-994;
(e) parent tag set 5, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOs:995-1052;
(f) parent tag set 6, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOS: 1053-1116;
(g) parent tag set 7, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOS: 1117-1180;
(h) parent tag set 8, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOs: 1181-1238;
(i) parent tag set 9, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOs: 1239-1302;
(j) a parent tag set 10 comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOs: 1303-1366;
(k) parent tag set 11, comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOS: 1367-1424;
(l) a set of two or more non-cross-reactive oligonucleotide tags selected from a parent tag set 12 comprising oligonucleotide tags having nucleotide sequences selected from SEQ ID NOs: 1425-1488.
(a)前記オリゴヌクレオチドを含む1つ以上の液滴を前記カーボンベースの支持体表面に印刷することと、
(b)前記液滴を前記表面に広げることを可能にすることと、
(c)前記液滴を乾燥させて乾燥液滴を形成することと、
(d)前記チオール基を介して前記オリゴヌクレオチドを前記カーボンベースの支持体表面に固定化することと、
(e)前記乾燥液滴を、チオール含有化合物を含む洗浄溶液で洗浄して、固定化されていないオリゴヌクレオチドを除去することと、を含む、方法。 A method of immobilizing oligonucleotides containing thiol groups to a carbon-based support surface, said method comprising:
(a) printing one or more droplets comprising said oligonucleotide onto said carbon-based support surface;
(b) allowing the droplet to spread over the surface;
(c) drying the droplets to form dried droplets;
(d) immobilizing the oligonucleotide to the carbon-based support surface via the thiol group;
(e) washing the dried droplets with a wash solution comprising a thiol-containing compound to remove non-immobilized oligonucleotides.
(a)前記1つ以上のカーボンベースの電極の表面上の複数の結合ドメイン上に1つ以上の捕捉オリゴヌクレオチドを含む液滴のアレイを印刷することであって、1つ以上の捕捉オリゴヌクレオチドが、チオール基を含む、印刷することと、
(b)前記液滴を前記表面に広げることを可能にすることと、
(c)前記液滴を乾燥させて乾燥液滴を形成することと、
(d)1つ以上のオリゴヌクレオチドを、前記チオール基を介して前記カーボンベースの電極の前記表面に固定化するのに十分な時間、前記乾燥液滴をインキュベートすることと、
(e)前記乾燥液滴を、チオール含有化合物を含む洗浄溶液で洗浄して、過剰な固定化されていないオリゴヌクレオチドを除去することと、を含む、方法。 A method of immobilizing an array of capture oligonucleotides on the surface of one or more carbon-based electrodes, said method comprising:
(a) printing an array of droplets comprising one or more capture oligonucleotides on a plurality of binding domains on the surface of said one or more carbon-based electrodes, said one or more capture oligonucleotides comprises a thiol group; and
(b) allowing the droplet to spread over the surface;
(c) drying the droplets to form dried droplets;
(d) incubating the dried droplets for a time sufficient to immobilize one or more oligonucleotides to the surface of the carbon-based electrode via the thiol groups;
(e) washing the dried droplets with a wash solution comprising a thiol-containing compound to remove excess non-immobilized oligonucleotides.
(b)請求項1~12のいずれか一項に記載の捕捉セットであって、前記捕捉セットが、1つ以上の支持体表面に固定化されている、捕捉セットと、
を含む、キット。 (a) one or more substrate surfaces;
(b) a capture set according to any one of claims 1-12 , wherein said capture set is immobilized on one or more support surfaces;
kit, including
(b)請求項1~12のいずれか一項に記載の捕捉セットであって、前記捕捉セットが、前記カーボンベースの電極の1つ以上の表面に固定化されている、捕捉セットと、
を含む、キット。 (a) one or more carbon-based electrodes having one or more surfaces;
(b) The capture set of any one of claims 1-12 , wherein said capture set is immobilized on one or more surfaces of said carbon-based electrode . and
kit, including
(a)
(i)1つ以上の表面を有する1つ以上のカーボンベースの電極と、
(ii)請求項1~12のいずれか一項に記載の捕捉セットであって、前記捕捉セットが、前記カーボンベースの電極の1つ以上の表面に固定化されている、捕捉セットと、
を含む、アレイを、1つ以上の標的分析物を含む組成物と接触させることであって、
前記1つ以上の標的分析物が、前記支持体表面および標識に固定化された捕捉オリゴヌクレオチドの少なくとも一部に相補的である標識およびオリゴヌクレオチドタグに会合する、接触させることと、
(b)前記オリゴヌクレオチドタグがそれらの対応する相補的捕捉オリゴヌクレオチドにハイブリダイズしてハイブリダイゼーション複合体を形成する条件下で、1つ以上の標的分析物の前記組成物をインキュベートすることと、
(c)アレイ位置における前記標識の存在または非存在に基づいて、前記標的分析物を同定、検出、または定量化することと、
を含む、方法。 A method of identifying, detecting, or quantifying a target analyte in a sample, said method comprising :
(a )
(i) one or more carbon-based electrodes having one or more surfaces;
(ii) a capture set according to any one of claims 1-12, wherein said capture set is immobilized on one or more surfaces of said carbon-based electrode;
contacting the array with a composition comprising one or more target analytes comprising
associating and contacting said one or more target analytes with labels and oligonucleotide tags that are complementary to at least a portion of capture oligonucleotides immobilized on said support surface and labels;
( b ) incubating said composition of one or more target analytes under conditions in which said oligonucleotide tags hybridize to their corresponding complementary capture oligonucleotides to form hybridization complexes;
( c ) identifying, detecting, or quantifying said target analyte based on the presence or absence of said label at array locations;
A method, including
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962843153P | 2019-05-03 | 2019-05-03 | |
US62/843,153 | 2019-05-03 | ||
US201962866512P | 2019-06-25 | 2019-06-25 | |
US62/866,512 | 2019-06-25 | ||
US202062963415P | 2020-01-20 | 2020-01-20 | |
US62/963,415 | 2020-01-20 | ||
PCT/US2020/030754 WO2020227016A1 (en) | 2019-05-03 | 2020-04-30 | Kits for detecting one or more target nucleic acid analytes in a sample and methods of making and using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022531421A JP2022531421A (en) | 2022-07-06 |
JPWO2020227016A5 true JPWO2020227016A5 (en) | 2023-05-11 |
Family
ID=70779917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021565115A Pending JP2022531421A (en) | 2019-05-03 | 2020-04-30 | A kit for detecting one or more target nucleic acid analytes in a sample and methods for making and using it. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230175043A1 (en) |
EP (1) | EP3963100A1 (en) |
JP (1) | JP2022531421A (en) |
KR (1) | KR20220044681A (en) |
CN (1) | CN114364815A (en) |
AU (1) | AU2020268813A1 (en) |
CA (1) | CA3138561A1 (en) |
IL (1) | IL287810A (en) |
SG (1) | SG11202111871WA (en) |
TW (1) | TW202108771A (en) |
WO (1) | WO2020227016A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021222832A1 (en) | 2020-05-01 | 2021-11-04 | Meso Scale Technologies, Llc. | Viral serology ace2 competition assays |
WO2022150711A1 (en) | 2021-01-11 | 2022-07-14 | Meso Scale Technologies, Llc. | Assay system calibration systems and methods |
IL305429A (en) * | 2021-02-26 | 2023-10-01 | Elips Diagnostics Inc | Novel electrochemiluminescence co-reactant, and electrochemiluminescence system comprising same |
EP4330672A1 (en) | 2021-04-26 | 2024-03-06 | Meso Scale Technologies, LLC. | Methods for isolating and analyzing a target analyte encapsulated by a surface marker displaying agent |
CN117859062A (en) * | 2021-04-26 | 2024-04-09 | 中尺度技术有限责任公司 | Multiple assay plate and method of making same |
WO2022246213A1 (en) | 2021-05-21 | 2022-11-24 | Meso Scale Techologies, Llc. | Assays for viral strain determination |
AU2022341113A1 (en) | 2021-09-09 | 2024-03-21 | Meso Scale Technologies, Llc. | Method for detecting sense and antisense strands in an oligonucleotide duplex |
WO2023245184A1 (en) | 2022-06-17 | 2023-12-21 | Meso Scale Technologies, Llc. | Viral strain serology assays |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521300A (en) * | 1991-08-13 | 1996-05-28 | Norval B. Galloway | Oligonucleotides complementary to mycobacterial nucleic acids |
US6673533B1 (en) | 1995-03-10 | 2004-01-06 | Meso Scale Technologies, Llc. | Multi-array multi-specific electrochemiluminescence testing |
US20020187470A1 (en) * | 1998-06-24 | 2002-12-12 | Casey Warren Michael | Detection of single nucleotide polymorphisms |
WO2003001889A2 (en) | 2001-06-29 | 2003-01-09 | Meso Scale Technologies, Llc. | Assay plates reader systems and methods for luminescence test measurements |
KR101489804B1 (en) | 2005-12-21 | 2015-02-05 | 메소 스케일 테크놀러지즈, 엘엘시 | Assay modules having assay reagents and methods of making and using same |
US9731297B2 (en) | 2011-01-06 | 2017-08-15 | Meso Scale Technologies, Llc. | Assay cartridges and methods of using the same |
SG11201506660RA (en) * | 2013-02-21 | 2015-09-29 | Toma Biosciences Inc | Methods, compositions, and kits for nucleic acid analysis |
CN105378477B9 (en) | 2013-03-11 | 2021-08-06 | 梅索磅秤技术有限公司 | Improved method for performing multiplex assays |
JP2016521575A (en) * | 2013-06-14 | 2016-07-25 | ナノストリング テクノロジーズ,インコーポレイティド | Multiplexable tag-based reporter system |
EP3204517B1 (en) * | 2014-10-10 | 2021-08-11 | Rutgers, the State University of New Jersey | Polymerase chain reaction primers and probes for mycobacterium tuberculosis |
ES2904514T3 (en) | 2015-04-06 | 2022-04-05 | Meso Scale Technologies Llc | High-throughput system for conducting assays using electrochemiluminescence that includes a consumable stirring apparatus |
AU2017299362A1 (en) | 2016-07-22 | 2019-02-21 | Meso Scale Technologies, Llc. | Integrated consumable data management system and platform |
KR20240052891A (en) | 2015-07-23 | 2024-04-23 | 메소 스케일 테크놀러지즈, 엘엘시 | Integrated consumable data management system and platform |
-
2020
- 2020-04-30 TW TW109114626A patent/TW202108771A/en unknown
- 2020-04-30 KR KR1020217039338A patent/KR20220044681A/en unknown
- 2020-04-30 EP EP20727485.3A patent/EP3963100A1/en active Pending
- 2020-04-30 WO PCT/US2020/030754 patent/WO2020227016A1/en unknown
- 2020-04-30 SG SG11202111871WA patent/SG11202111871WA/en unknown
- 2020-04-30 AU AU2020268813A patent/AU2020268813A1/en active Pending
- 2020-04-30 CA CA3138561A patent/CA3138561A1/en active Pending
- 2020-04-30 US US17/607,731 patent/US20230175043A1/en active Pending
- 2020-04-30 CN CN202080045391.2A patent/CN114364815A/en active Pending
- 2020-04-30 JP JP2021565115A patent/JP2022531421A/en active Pending
-
2021
- 2021-11-02 IL IL287810A patent/IL287810A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2789383B1 (en) | Molecular arrays | |
EP2350648B1 (en) | Selective processing of biological material on a microarray substrate | |
US20140377750A1 (en) | Methods and Systems for Detecting Nucleic Acids | |
EP2647426A1 (en) | Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding | |
US20030003495A1 (en) | Systems, tools and methods of assaying biological materials using spatially-addressable arrays | |
CA2312052A1 (en) | Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry | |
CA2425112A1 (en) | Massive parallel method for decoding dna and rna | |
EP1687406A4 (en) | Nucleic acid detection method having increased sensitivity | |
CN114364815A (en) | Kits for detecting one or more target analytes in a sample and methods of making and using same | |
JP4388369B2 (en) | Sorting and immobilization system for nucleic acids using a synthetic binding system | |
JPWO2020227016A5 (en) | ||
Manning et al. | A versatile multi-platform biochip surface attachment chemistry | |
IL300973A (en) | Kits for detecting one or more target analytes in a sample and methods of making and using the same | |
US20120171503A1 (en) | Carrier for holding nucleic acid | |
Gudnason et al. | An inexpensive and simple method for thermally stable immobilization of DNA on an unmodified glass surface: UV linking of poly (T) 10-poly (C) 10–tagged DNA probes | |
WO2001021838A2 (en) | Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms | |
US20070190537A1 (en) | Solid phase synthesis | |
US9110056B2 (en) | Surface treatment | |
JP2001128683A (en) | Method for fixing dna fragment and method for detecting dna chip and nucleic acid fragment | |
Murtaza et al. | DNA microrray: A miniaturized high throughput technology | |
Pierik et al. | Immobilization of oligonucleotides with homo-oligomer tails onto amine-functionalized solid substrates and the effects on hybridization | |
JP4521556B2 (en) | Method for improving sensitivity in analysis of polynucleotide samples | |
JP6032721B2 (en) | Immobilized polynucleotide | |
JP2010284159A (en) | Probe having high specificity, nucleic acid array using the same and method for producing the same | |
WO2004044242A1 (en) | Polymorphism assay |